The Global Pharmaceuticals sector witnessed 5 Partnerships deals in July 2022, for an aggregate deal value of $1,862.4 million. This represents a decrease of 9.8% in terms of value and a decrease of 44.0% in terms of volume, year over year.
A total of 75 Partnerships deals were recorded over the last twelve months (LTM) for an aggregate deal value of $43,224.2 million. In the LTM period, January 2022, turned out to be the most prolific in terms of deal size, with a total deal value of $195.4 million and a deal volume of 3 during that month. On the other hand, the month of January 2022, was the most prolific in terms of deal volume, recording a total of 15 deals with a total deal value of $9,633.0 million during that month.
On an average, over the LTM period, 6 deals were done with an average deal size of $3,602.0 million.
United States of America
China
United States of America
United States of America
United States of America
United States of America
France
United States of America
United States of America
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer